CJ
Corinne Johnson Goldman Sachs Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
9
Avg Return
Past Year
Past Year
35%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
70%
Neutral
20%
Negative
10%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Maintained
| $39 |
33%
upside
| 1 | – |
–
| 15 Jan ‘26 1 month ago |
|
|
|
Neutral
Maintained
| $28 |
9%
upside
| 1 | – |
–
| 15 Dec ‘25 2 months ago |
|
|
|
Sell
Initiated
| $18 |
38%
downside
| 1 | +15% |
0
%
| 4 Dec ‘25 3 months ago |
|
|
|
Buy
Maintained
| $20 |
34%
upside
| 2 | +45% |
0
%
| 16 Sep ‘25 5 months ago |
|
|
|
Buy
Maintained
| $24 |
1%
downside
| 2 | +62% |
0
%
| 5 Sep ‘25 6 months ago |
|
|
|
Buy
Reinstated
| $55 | – | 1 | +133% |
0
%
| 10 Jul ‘25 8 months ago |
|
|
|
Buy
Reinstated
| $33 |
30%
upside
| 1 | +19% |
0
%
| 10 Jul ‘25 8 months ago |
|
|
|
Buy
Initiated
| $182 |
40%
upside
| 1 | -2.7% |
0
%
| 10 Jul ‘25 8 months ago |
|